Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthesis of methylmercapto-substituted arabinose triazole spiroisoxazole-pyrrolizine derivatives via 1,3-dipolar cycloaddition for potent antitumor applications.
Patent CN111548383B details a scalable chemical resolution route for NMN, offering cost reduction in nutraceutical manufacturing and enhanced supply chain reliability.
Novel copper-catalyzed oxidative coupling for high-purity maleimide derivatives. Reduces cost and improves supply chain reliability for pharma intermediates.
Patent CN103204890A details a low-toxicity phosphorylation method for Vidarabine Monophosphate. Discover cost-effective manufacturing and supply chain advantages.
Patent CN109206465A reveals a two-step synthesis for Adenosine Cyclophosphate offering reduced solvent use and high purity for reliable pharmaceutical intermediates supply chains.
Novel synthesis route for tenofovir intermediates offers high yield and cost reduction. Reliable supply chain for pharmaceutical manufacturing partners globally.
Patent CN106831702A reveals a zeolite-catalyzed route for high-purity thiophenic acid. This process offers significant cost reduction and supply chain reliability for API intermediate manufacturing.
Patent CN107602454B details a robust synthesis for potent HIV-1 protease inhibitors. Discover cost-effective manufacturing strategies and supply chain advantages.
Patent CN117777051B reveals efficient synthesis for pharmaceutical intermediates. Achieve high purity and cost reduction with scalable thiazole manufacturing processes.
Patent CN102285984B details stereoselective reduction for DHTBZ. Enhances purity and yield for pharmaceutical intermediate manufacturing supply chains.
Novel patent CN104710411B offers high-yield avanafil synthesis without cryogenic conditions or heavy metals ensuring cost reduction and supply reliability for global buyers
Patent CN110551771B details a green enzymatic route for chiral 3-amino-1-butanol. Discover cost-effective, high-purity pharmaceutical intermediate manufacturing solutions.
Patent CN119710733B reveals electrochemical C-H functionalization for indole derivatives. Offers cost reduction and scalable supply chain solutions for pharma intermediates.
Novel Ru-Cu catalytic route for biarylpyrrole derivatives offers short synthesis and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN112625041A discloses a novel entecavir synthesis using protected purine intermediates, significantly improving yield and purity for reliable API manufacturing.
Discover the patented CN102603543B method for Mexiletine Hydrochloride. Achieve >99.5% purity with eco-friendly processes. Reliable pharmaceutical intermediates supplier insights.
Patent CN102127135A reveals a mild, gold-catalyzed glycosylation method for pyrimidine and purine nucleosides, offering significant cost reduction in API manufacturing.
Novel 5-step route for lenalidomide preparation using 3-amino-2-methylbenzoic acid. High purity, mild conditions, scalable industrial process for API manufacturing.
Patent CN106188193A reveals a novel N-protection strategy for Sofosbuvir intermediates, ensuring high purity, reduced impurities, and scalable manufacturing for global supply chains.
Patent CN110627610B enables cost reduction in fine chemical manufacturing via copper-catalyzed asymmetric coupling. Secure high-purity chiral alkynes supply chain today.